Dennis E. Marshall - 31 Dec 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, attorney-in-fact
Issuer symbol
BLGO
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 16:56:21 UTC
Previous filing
29 Dec 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award +96,154 +2.7% 3,686,508 31 Dec 2022 Common Stock 96,154 $0.1950 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.